• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种结合患者报告结局指标、肺功能测定和呼出一氧化氮分数用于哮喘诊断的预测模型的开发与验证

Development and validation of a predictive model combining patient-reported outcome measures, spirometry and exhaled nitric oxide fraction for asthma diagnosis.

作者信息

Louis Gilles, Schleich Florence, Guillaume Michèle, Kirkove Delphine, Nekoee Zahrei Halehsadat, Donneau Anne-Françoise, Henket Monique, Paulus Virginie, Guissard Françoise, Louis Renaud, Pétré Benoit

机构信息

Department of Public Health, University of Liège, Liege, Belgium.

Department of Pneumology, GIGAI3, University of Liège, Liege, Belgium.

出版信息

ERJ Open Res. 2023 Feb 6;9(1). doi: 10.1183/23120541.00451-2022. eCollection 2023 Jan.

DOI:10.1183/23120541.00451-2022
PMID:36755965
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9900444/
Abstract

INTRODUCTION

Although asthma is a common disease, its diagnosis remains a challenge in clinical practice with both over- and underdiagnosis. Here, we performed a prospective observational study investigating the value of symptom intensity scales alone or combined with spirometry and exhaled nitric oxide fraction ( ) to aid in asthma diagnosis.

METHODS

Over a 38-month period we recruited 303 untreated patients complaining of symptoms suggestive of asthma (wheezing, dyspnoea, cough, sputum production and chest tightness). The whole cohort was split into a training cohort (n=166) for patients recruited during odd months and a validation cohort (n=137) for patients recruited during even months. Asthma was diagnosed either by a positive reversibility test (≥12% and ≥200 mL in forced expiratory volume in 1 s (FEV)) and/or a positive bronchial challenge test (provocative concentration of methacholine causing a 20% fall in FEV ≤8 mg·mL). In order to assess the diagnostic performance of symptoms, spirometric indices and , we performed receiver operating characteristic curve analysis and multivariable logistic regression to identify the independent factors associated with asthma in the training cohort. Then, the derived predictive models were applied to the validation cohort.

RESULTS

63% of patients in the derivation cohort and 58% of patients in the validation cohort were diagnosed as being asthmatic. After logistic regression, wheezing was the only symptom to be significantly associated with asthma. Similarly, FEV (% pred), FEV/forced vital capacity (%) and were significantly associated with asthma. A predictive model combining these four parameters yielded an area under the curve of 0.76 (95% CI 0.66-0.84) in the training cohort and 0.73 (95% CI 0.65-0.82) when applied to the validation cohort.

CONCLUSION

Combining a wheezing intensity scale with spirometry and may help in improving asthma diagnosis accuracy in clinical practice.

摘要

引言

尽管哮喘是一种常见疾病,但在临床实践中,其诊断仍然是一项挑战,存在过度诊断和诊断不足的情况。在此,我们进行了一项前瞻性观察性研究,调查单独使用症状强度量表或结合肺功能测定和呼出一氧化氮分数( )辅助哮喘诊断的价值。

方法

在38个月的时间里,我们招募了303名未经治疗的患者,他们主诉有提示哮喘的症状(喘息、呼吸困难、咳嗽、咳痰和胸闷)。整个队列被分为一个训练队列(n = 166),用于奇数月招募的患者,以及一个验证队列(n = 137),用于偶数月招募的患者。哮喘通过阳性可逆性试验(一秒用力呼气量(FEV)增加≥12%且≥200 mL)和/或阳性支气管激发试验(引起FEV下降20%的乙酰甲胆碱激发浓度≤8 mg·mL)进行诊断。为了评估症状、肺功能指标和 的诊断性能,我们进行了受试者操作特征曲线分析和多变量逻辑回归,以确定训练队列中与哮喘相关的独立因素。然后,将推导的预测模型应用于验证队列。

结果

推导队列中63%的患者和验证队列中58%的患者被诊断为哮喘。经过逻辑回归分析,喘息是唯一与哮喘显著相关的症状。同样,FEV(%预计值)、FEV/用力肺活量(%)和 与哮喘显著相关。结合这四个参数的预测模型在训练队列中的曲线下面积为0.76(95%可信区间0.66 - 0.84),应用于验证队列时为0.73(95%可信区间0.65 - 0.82)。

结论

将喘息强度量表与肺功能测定和 相结合可能有助于提高临床实践中哮喘诊断的准确性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acbc/9900444/fbbfd8516481/00451-2022.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acbc/9900444/2ca35116a838/00451-2022.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acbc/9900444/fbbfd8516481/00451-2022.02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acbc/9900444/2ca35116a838/00451-2022.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acbc/9900444/fbbfd8516481/00451-2022.02.jpg

相似文献

1
Development and validation of a predictive model combining patient-reported outcome measures, spirometry and exhaled nitric oxide fraction for asthma diagnosis.一种结合患者报告结局指标、肺功能测定和呼出一氧化氮分数用于哮喘诊断的预测模型的开发与验证
ERJ Open Res. 2023 Feb 6;9(1). doi: 10.1183/23120541.00451-2022. eCollection 2023 Jan.
2
Anticipating undiagnosed asthma in symptomatic adults with normal pre- and post-bronchodilator spirometry: a decision tool for bronchial challenge testing.在支气管扩张剂预后肺功能正常的有症状的成年人群中预测未诊断的哮喘:支气管激发试验的决策工具。
BMC Pulm Med. 2023 Dec 9;23(1):496. doi: 10.1186/s12890-023-02806-9.
3
The Use of Exercise Challenge Testing and Fractional Exhaled Nitric Oxide in Diagnosis of Chest Tightness Variant Asthma in Children.运动激发试验和呼出气一氧化氮测定在儿童胸闷变异性哮喘诊断中的应用。
Int Arch Allergy Immunol. 2022;183(7):762-769. doi: 10.1159/000522062. Epub 2022 Feb 14.
4
Combining spirometry and fractional exhaled nitric oxide improves diagnostic accuracy for childhood asthma.结合肺量计检查和呼出一氧化氮分数可提高儿童哮喘的诊断准确性。
Clin Respir J. 2020 Jan;14(1):21-28. doi: 10.1111/crj.13095. Epub 2019 Oct 22.
5
Diagnosis of asthma in children: the contribution of a detailed history and test results.儿童哮喘的诊断:详细病史和检查结果的贡献。
Eur Respir J. 2019 Dec 4;54(6). doi: 10.1183/13993003.01326-2019. Print 2019 Dec.
6
Comparison of exhaled nitric oxide measurement with conventional tests in steroid-naive asthma patients.初治哮喘患者呼出一氧化氮测量与传统检测方法的比较。
J Investig Allergol Clin Immunol. 2006;16(4):239-46.
7
Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children.儿童呼出一氧化氮与持续性哮喘的临床及炎症标志物的关系
J Allergy Clin Immunol. 2003 Nov;112(5):883-92. doi: 10.1016/j.jaci.2003.08.014.
8
Evaluation of exhaled nitric oxide's ability to predict methacholine challenge in adults with nonobstructive spirometry.评价呼出气一氧化氮预测非阻塞性肺功能测定成年人乙酰甲胆碱激发试验的能力。
Ann Allergy Asthma Immunol. 2016 Oct;117(4):365-369.e1. doi: 10.1016/j.anai.2016.07.032. Epub 2016 Aug 23.
9
Assessment of diagnostic accuracy of lung function indices and FeNO for a positive methacholine challenge.评估肺功能指标和 FeNO 对乙酰甲胆碱激发试验阳性的诊断准确性。
Biochem Pharmacol. 2020 Sep;179:113981. doi: 10.1016/j.bcp.2020.113981. Epub 2020 Apr 17.
10
A rapid dosimetric methacholine challenge in asthma diagnostics: a clinical study of 230 patients with dyspnoea, wheezing or a cough of unknown cause.一种用于哮喘诊断的快速剂量法乙酰甲胆碱激发试验:对230例病因不明的呼吸困难、喘息或咳嗽患者的临床研究。
Respir Med. 1998 Jan;92(1):32-9. doi: 10.1016/s0954-6111(98)90029-4.

引用本文的文献

1
Machine learning algorithms for the clinical diagnosis of acute atypical asthma exacerbation.用于急性非典型哮喘加重期临床诊断的机器学习算法
Am J Transl Res. 2025 Apr 15;17(4):2916-2926. doi: 10.62347/YUOT5902. eCollection 2025.
2
30-day Spirometry Holter method design and prospective observational study.30 天肺量计动态 Holter 法设计与前瞻性观察研究。
Sci Rep. 2024 Oct 31;14(1):26204. doi: 10.1038/s41598-024-77803-x.
3
Fractional Exhaled Nitric Oxide Testing for the Diagnosis and Management of Asthma: a Health Technology Assessment.

本文引用的文献

1
Asthma diagnosis using patient-reported outcome measures and objective diagnostic tests: now and into the future.使用患者报告结局指标和客观诊断测试进行哮喘诊断:现状与未来。
Curr Opin Pulm Med. 2022 May 1;28(3):251-257. doi: 10.1097/MCP.0000000000000871. Epub 2022 Mar 7.
2
European Respiratory Society guidelines for the diagnosis of asthma in adults.欧洲呼吸学会成人哮喘诊断指南。
Eur Respir J. 2022 Sep 7;60(3). doi: 10.1183/13993003.01585-2021. Print 2022 Sep.
3
Clinical value of bronchodilator response for diagnosing asthma in steroid-naïve adults.
呼出气一氧化氮测定在哮喘诊断和管理中的应用:一项卫生技术评估。
Ont Health Technol Assess Ser. 2024 Jul 31;24(5):1-225. eCollection 2024.
4
Association of Cough Severity with Asthma Control and Quality of Life in Patients with Severe Asthma.咳嗽严重程度与重度哮喘患者哮喘控制和生活质量的相关性。
Lung. 2024 Aug;202(4):405-414. doi: 10.1007/s00408-024-00710-5. Epub 2024 Jun 7.
5
Deriving and validating an asthma diagnosis prediction model for children and young people in primary care.推导并验证用于基层医疗中儿童和青少年的哮喘诊断预测模型。
Wellcome Open Res. 2023 Sep 7;8:195. doi: 10.12688/wellcomeopenres.19078.2. eCollection 2023.
6
Update on the Role of FeNO in Asthma Management.呼出气一氧化氮在哮喘管理中的作用最新进展
Diagnostics (Basel). 2023 Apr 15;13(8):1428. doi: 10.3390/diagnostics13081428.
支气管扩张剂反应在未使用过类固醇的成人哮喘诊断中的临床价值。
ERJ Open Res. 2021 Dec 13;7(4). doi: 10.1183/23120541.00293-2021. eCollection 2021 Oct.
4
NOVELTY: a landmark study in phenotyping and endotyping chronic obstructive airway diseases in real clinical practice.新颖性:一项在实际临床实践中对慢性阻塞性气道疾病进行表型分析和内型分析的里程碑式研究。
Eur Respir J. 2021 Sep 23;58(3). doi: 10.1183/13993003.00627-2021. Print 2021 Sep.
5
The applications of eHealth technologies in the management of asthma and allergic diseases.电子健康技术在哮喘和过敏性疾病管理中的应用。
Clin Transl Allergy. 2021 Sep 6;11(7):e12061. doi: 10.1002/clt2.12061. eCollection 2021 Aug.
6
Predictors of asthma-related quality of life in a large cohort of asthmatics: A cross-sectional study in a secondary care center.一大群哮喘患者中哮喘相关生活质量的预测因素:在一家二级护理中心进行的横断面研究。
Clin Transl Allergy. 2021 Sep 3;11(7):e12054. doi: 10.1002/clt2.12054. eCollection 2021 Aug.
7
Diagnosing Asthma with and without Aerosol-Generating Procedures.无气溶胶生成操作与有气溶胶生成操作下的哮喘诊断。
J Allergy Clin Immunol Pract. 2021 Dec;9(12):4243-4251.e7. doi: 10.1016/j.jaip.2021.07.006. Epub 2021 Jul 21.
8
European Respiratory Society clinical practice guidelines for the diagnosis of asthma in children aged 5-16 years.欧洲呼吸学会儿童哮喘诊断临床实践指南(5-16 岁)
Eur Respir J. 2021 Nov 4;58(5). doi: 10.1183/13993003.04173-2020. Print 2021 Oct.
9
Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort.医生诊断的哮喘和/或慢性阻塞性肺疾病内部及之间的异质性:新型队列研究。
Eur Respir J. 2021 Sep 23;58(3). doi: 10.1183/13993003.03927-2020. Print 2021 Sep.
10
Asthma diagnosis: into the fourth dimension.哮喘诊断:进入第四维度。
Thorax. 2021 Jun;76(6):624-631. doi: 10.1136/thoraxjnl-2020-216421. Epub 2021 Jan 27.